0.5342 -0.071 (-11.79%) | 02-11 16:00 | |||||||||||||
|
|
Short term | ![]() |
|||
Mid term | ![]() ![]() ![]() |
|||
Targets | 6-month : | 1.56 | 1-year : | 2.48 |
Resists | First : | 1.33 | Second : | 2.13 |
Pivot price | 0.35 ![]() |
|||
Supports | First : | 0.05 | Second : | 0.04 |
MAs | MA(5) : | 0.61 ![]() |
MA(20) : | 0.28 ![]() |
MA(100) : | 0.95 ![]() |
MA(250) : | 1.63 ![]() |
|
MACD | MACD : | 0.1 ![]() |
Signal : | 0 ![]() |
%K %D | K(14,3) : | 26.1 ![]() |
D(3) : | 27.6 ![]() |
RSI | RSI(14): 60.4 ![]() |
|||
52-week | High : | 4.94 | Low : | 0.05 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ GCTK ] has closed below upper band by 34.4%. Bollinger Bands are 63.7% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue.
If tomorrow: | Open lower | Open higher |
High: | 0.59 - 0.59 | 0.59 - 0.6 |
Low: | 0.48 - 0.48 | 0.48 - 0.49 |
Close: | 0.53 - 0.54 | 0.54 - 0.54 |
GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.
Tue, 04 Feb 2025
GCTK - GlucoTrack, Inc. Latest Stock News & Market Updates - StockTitan
Tue, 04 Feb 2025
Diabetes Tech Pioneer Glucotrack Raises Fresh Capital: Key Details of $3M Share Offering Revealed - StockTitan
Tue, 04 Feb 2025
Glucotrack soars on completion of first human clinical study of continuous blood glucose monitor - Seeking Alpha
Tue, 04 Feb 2025
Revolutionary Blood Glucose Monitor Shows Promise: Direct Blood Measurement Could Transform Diabetes Care - StockTitan
Thu, 30 Jan 2025
Glucotrack announces 1-for-20 reverse stock split - Investing.com
Thu, 30 Jan 2025
Glucotrack's Strategic Move: 1-for-20 Reverse Split Could Save Nasdaq Listing - StockTitan
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
Exchange:
NASDAQ
|
|
Sector:
Healthcare
|
|
Industry:
Medical - Instruments & Supplies
|
|
Shares Out | 155 (M) |
Shares Float | 4 (M) |
Held by Insiders | 34.9 (%) |
Held by Institutions | 0.9 (%) |
Shares Short | 38 (K) |
Shares Short P.Month | 24 (K) |
EPS | -2.92 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0.75 |
Profit Margin | 0 % |
Operating Margin | 0 % |
Return on Assets (ttm) | -157.5 % |
Return on Equity (ttm) | -541.2 % |
Qtrly Rev. Growth | 0 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0 |
EBITDA (p.s.) | -0.08 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | -9 (M) |
Levered Free Cash Flow | -5 (M) |
PE Ratio | -0.19 |
PEG Ratio | 0 |
Price to Book value | 0.7 |
Price to Sales | 0 |
Price to Cash Flow | -9.09 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |